“Clean meat” is receiving significant venture capital funding
Biotechnology has come a long way since 1978, when Herbert Boyer successfully demonstrated that human insulin could be produced from bacteria engineered with recombinant DNA. The breakthrough technology pushed a little-known company called Genentech into the spotlight and forever changed the world. Genentech was acquired by Roche for $46.8 billion in 2009. The American bioeconomy — biotech crops, biochemicals, and biologic drugs — generated an estimated $324 billion of gross domestic product in 2012. And millions of people worldwide today rely on insulin and other biologic drugs daily.
READ THE FULL ARTICLE AT: https://host.madison.com/business/investment/markets-and-stocks/incredible-synthetic-biology-holy-grails-that-could-change-the-world/article_6a159dcf-8042-5936-b542-6403a1c7811b.html